Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 50090-7681

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 50090-7681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907681)

Label for Olmesartan Medoxomil 40 mg film-coated tablets by A-S Medication Solutions. Contains dosing and storage instructions, with a package size of 90 tablets. Displays the NDC number 50090-7681-0 and includes a barcode and lot number information.*

FDA Label Image

Logo0001-01 (Logo0001 01)

FDA Label Image

Chemical Structure (Olmesartan Medoxomil Figure 1)

Chemical structure diagram of Olmesartan medoxomil, showing its molecular framework with rings, chains, and functional groups as part of the active ingredient in the Olmesartan medoxomil 40 mg film-coated tablet by A-S Medication Solutions.*

FDA Label Image

Figure (Olmesartan Medoxomil Figure 2)

A dose-response line graph titled 'Olmesartan Medoxomil Dose Response Placebo-Adjusted Reduction In Blood Pressure (mmHg)'. It depicts reductions in systolic and diastolic blood pressure (mmHg) on the y-axis versus Olmesartan Medoxomil dose in mg on the x-axis. Two lines are shown: one for systolic BP (circles) and one for diastolic BP (triangles), illustrating greater reductions with increasing dose up to about 80 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.